Brady Martz Wealth Solutions LLC Invests $279,000 in Synopsys, Inc. (NASDAQ:SNPS)

Brady Martz Wealth Solutions LLC acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 569 shares of the semiconductor company's stock, valued at approximately $279,000.

Other hedge funds have also made changes to their positions in the company. Pacifica Partners Inc. purchased a new stake in shares of Synopsys during the third quarter worth approximately $25,000. Kieckhefer Group LLC purchased a new stake in shares of Synopsys during the fourth quarter worth $27,000. Tsfg LLC grew its holdings in shares of Synopsys by 75.0% during the third quarter. Tsfg LLC now owns 56 shares of the semiconductor company's stock worth $28,000 after buying an additional 24 shares in the last quarter. Hazlett Burt & Watson Inc. raised its position in shares of Synopsys by 40.0% in the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company's stock valued at $35,000 after buying an additional 20 shares during the last quarter. Finally, Princeton Global Asset Management LLC purchased a new position in shares of Synopsys in the third quarter worth about $44,000. Institutional investors and hedge funds own 85.47% of the company's stock.

Synopsys Stock Up 2.1 %

Shares of SNPS traded up $10.89 during trading on Monday, reaching $526.70. 1,240,502 shares of the company traded hands, compared to its average volume of 870,192. The stock has a 50-day simple moving average of $519.43 and a 200-day simple moving average of $525.54. The stock has a market cap of $81.42 billion, a PE ratio of 36.27, a price-to-earnings-growth ratio of 3.22 and a beta of 1.12. Synopsys, Inc. has a twelve month low of $457.52 and a twelve month high of $629.38.

Insider Activity at Synopsys

In related news, CRO Richard S. Mahoney sold 20,838 shares of the firm's stock in a transaction dated Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the completion of the transaction, the executive now directly owns 1,460 shares in the company, valued at $738,774.60. This trade represents a 93.45 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.66% of the stock is owned by insiders.

Analyst Ratings Changes

A number of analysts have commented on SNPS shares. Needham & Company LLC reiterated a "buy" rating and issued a $640.00 price objective on shares of Synopsys in a report on Thursday, December 5th. Loop Capital assumed coverage on Synopsys in a report on Monday, November 11th. They issued a "buy" rating and a $675.00 price target for the company. Robert W. Baird lowered their price objective on Synopsys from $644.00 to $630.00 and set an "outperform" rating on the stock in a research note on Thursday, December 5th. Redburn Atlantic started coverage on Synopsys in a research note on Monday, January 13th. They issued a "buy" rating and a $600.00 target price for the company. Finally, Mizuho assumed coverage on shares of Synopsys in a research report on Tuesday, October 22nd. They set an "outperform" rating and a $650.00 price target on the stock. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the company's stock. According to MarketBeat, Synopsys currently has an average rating of "Moderate Buy" and an average price target of $641.82.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.